Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J F de Groot

Showing results (1-10 of 9) with videos related to

Pageof 1
Sort By:
Journal De Biologie Buccale|June 1, 1986
Some aspects of artificial caries lesion formation of human dental enamel in vitroJ F de Groot, J M Borggreven, F C Driessens
Journal of Pediatric Rehabilitation Medicine|June 28, 2013
Validation of the Actical and Actiheart monitor in ambulatory children with spina bifidaJ F de Groot, A S de Jong, T Visser, et al.
European Journal of Applied Physiology|July 12, 2008
Limiting factors in peak oxygen uptake and the relationship with functional ambulation in ambulating children with spina bifidaJ F De Groot, T Takken, M A G C Schoenmakers, et al.
Gait & Posture|October 31, 2009
Reproducibility of energy cost of locomotion in ambulatory children with spina bifidaJ F De Groot, T Takken, M A G C Schoenmakers, et al.
Disability and Rehabilitation. Assistive Technology|April 24, 2019
Wheelchair Mobility Confidence Scale for Dutch youth using a manual wheelchairM E Sol, M A T Bloemen, O Verschuren, et al.
Physiotherapy Theory and Practice|August 10, 2010
Feasibility and preliminary effectiveness of preoperative therapeutic exercise in patients with cancer: a pragmatic studyH Timmerman, J F de Groot, H J Hulzebos, et al.
BMC Pediatrics|April 8, 2018
Implementing paediatric early warning scores systems in the Netherlands: future implicationsJ F de Groot, N Damen, E de Loos, et al.
Thrombosis Journal|August 9, 2019
Guideline compliance for bridging anticoagulation use in vitamin-K antagonist patients; practice variation and factors associated with non-complianceM J Moesker, J F de Groot, N L Damen, et al.
Journal of Neuro-Oncology|June 27, 2008
Phase II study of carboplatin and erlotinib (Tarceva, OSI-774) in patients with recurrent glioblastomaJ F de Groot, M R Gilbert, K Aldape, et al.
Pageof 1

Showing results (1-10 of 9) with videos related to

Sort By:
Pageof 1
Journal De Biologie Buccale|June 1, 1986
Some aspects of artificial caries lesion formation of human dental enamel in vitroJ F de Groot, J M Borggreven, F C Driessens
Journal of Pediatric Rehabilitation Medicine|June 28, 2013
Validation of the Actical and Actiheart monitor in ambulatory children with spina bifidaJ F de Groot, A S de Jong, T Visser, et al.
European Journal of Applied Physiology|July 12, 2008
Limiting factors in peak oxygen uptake and the relationship with functional ambulation in ambulating children with spina bifidaJ F De Groot, T Takken, M A G C Schoenmakers, et al.
Gait & Posture|October 31, 2009
Reproducibility of energy cost of locomotion in ambulatory children with spina bifidaJ F De Groot, T Takken, M A G C Schoenmakers, et al.
Disability and Rehabilitation. Assistive Technology|April 24, 2019
Wheelchair Mobility Confidence Scale for Dutch youth using a manual wheelchairM E Sol, M A T Bloemen, O Verschuren, et al.
Physiotherapy Theory and Practice|August 10, 2010
Feasibility and preliminary effectiveness of preoperative therapeutic exercise in patients with cancer: a pragmatic studyH Timmerman, J F de Groot, H J Hulzebos, et al.
BMC Pediatrics|April 8, 2018
Implementing paediatric early warning scores systems in the Netherlands: future implicationsJ F de Groot, N Damen, E de Loos, et al.
Thrombosis Journal|August 9, 2019
Guideline compliance for bridging anticoagulation use in vitamin-K antagonist patients; practice variation and factors associated with non-complianceM J Moesker, J F de Groot, N L Damen, et al.
Journal of Neuro-Oncology|June 27, 2008
Phase II study of carboplatin and erlotinib (Tarceva, OSI-774) in patients with recurrent glioblastomaJ F de Groot, M R Gilbert, K Aldape, et al.
Pageof 1